BVS
Bioventus Inc.
NASDAQ · Healthcare · Medical - Devices · US
$10.95
−16.77%Next report
Analyst consensus
- Next report date
- Mar 11, 2027
- EPS estimate
- $0.22
- Revenue estimate
- $166.7M
Latest reported
- Last report date
- Nov 2, 2026
- EPS actual
- $0.17
- EPS estimate
- $0.15
- Revenue actual
- $142.4M
- Revenue estimate
- $149.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +23.3%
- Revenue beats (12Q)
- 6
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $17
- PT range
- $15 – $18
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Nov 2, 2026 | $0.15 | $0.17 | Beat 13.64% | $142.4M |
| Aug 5, 2026 | $0.22 | $0.22 | Beat 1.71% | $153.2M |
| May 6, 2026 | $0.09 | $0.15 | Beat 66.67% | $132.1M |
| Mar 5, 2026 | $0.22 | $0.24 | Beat 11.21% | $157.9M |
| Mar 11, 2025 | $0.08 | $0.15 | Beat 87.50% | $153.6M |
| Mar 12, 2024 | $0.06 | $0.07 | Beat 16.67% | $135.4M |
| May 16, 2023 | -$0.11 | -$0.26 | Miss -136.36% | $119.1M |
| Mar 31, 2023 | $0.05 | -$0.06 | Miss -220.00% | $125.8M |
| Nov 21, 2022 | $0.13 | $0.05 | Miss -61.54% | $128.7M |
| Aug 11, 2022 | $0.14 | $0.10 | Miss -28.57% | $140.3M |
| Mar 10, 2022 | $0.20 | $0.26 | Beat 30.00% | $130.4M |
| Aug 10, 2021 | $0.10 | $0.16 | Beat 60.00% | $109.8M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 11, 2027